Here's a similar list. When in doubt, trust the linked 10-Q filing from sec.gov. Not sure why the Mcap/Cash value is left-justified against the Market Cap. Those values are all formatted X.XX and are centered in my spreadsheet.
| Ticker | Company Name | Cash | Shares | PPS | Market Cap | Mcap/Cash | Filing | | DNAI | ProNAi Therapeutics Inc | $130,550,000 | 30,325,124 | $1.53 | $46,397,440 | 0.36 | 10-Q | | CBYL | Carbylan Therapeutics, Inc. | $36,819,000 | 26,335,775 | $0.51 | $13,415,444 | 0.36 | 10-Q | | TLOG | TETRALOGIC PHARMACEUTICALS CORP | $8,675,724 | 24,769,083 | $0.15 | $3,653,440 | 0.42 | 10-Q | | CERU | Cerulean Pharma Inc. | $47,193,000 | 27,384,492 | $0.80 | $21,907,594 | 0.46 | 10-Q | | INFI | INFINITY PHARMACEUTICALS, INC. | $122,351,000 | 49,587,998 | $1.22 | $60,497,358 | 0.49 | 10-Q | | AAVL | Adverum Biotechnologies, Inc. | $241,302,000 | 41,348,194 | $2.97 | $122,804,136 | 0.51 | 10-Q | | OREX | Orexigen Therapeutics, Inc. | $78,173,000 | 14,586,771 | $2.75 | $40,113,620 | 0.51 | 10-Q | | NURO | NeuroMetrix, Inc. | $11,330,857 | 5,118,273 | $1.32 | $6,735,647 | 0.59 | 10-Q | | MRNS | MARINUS PHARMACEUTICALS INC | $39,102,000 | 19,509,220 | $1.21 | $23,606,156 | 0.60 | 10-Q | | MSTX | Mast Therapeutics, Inc. | $24,490,000 | 211,815,450 | $0.08 | $16,521,605 | 0.67 | 10-Q | | IMGN | IMMUNOGEN INC | $245,026,000 | 87,326,441 | $1.92 | $167,666,767 | 0.68 | 10-K | | ZSAN | Zosano Pharma Corp | $10,057,000 | 12,015,997 | $0.59 | $7,078,624 | 0.70 | 10-Q | | GNVC | GENVEC INC | $9,630,000 | 22,736,316 | $0.30 | $6,820,895 | 0.71 | 10-Q | | TTPH | TETRAPHASE PHARMACEUTICALS INC | $178,311,000 | 36,698,560 | $3.55 | $130,279,888 | 0.73 | 10-Q | | IRWD | IRONWOOD PHARMACEUTICALS INC | $277,332,000 | 15,385,236 | $13.19 | $202,931,263 | 0.73 | 10-Q | | IDXG | Interpace Diagnostics Group, Inc. | $3,039,000 | 18,162,671 | $0.13 | $2,270,334 | 0.75 | 10-Q | | CBIO | CATALYST BIOSCIENCES, INC. | $11,333,000 | 11,835,864 | $0.73 | $8,640,181 | 0.76 | 10-Q | | NEOT | Neothetics, Inc. | $21,471,803 | 13,815,589 | $1.20 | $16,578,707 | 0.77 | 10-Q | | TNXP | Tonix Pharmaceuticals Holding Corp. | $14,938,000 | 25,860,431 | $0.45 | $11,559,613 | 0.77 | 10-Q | | CYTR | CYTRX CORP | $55,913,199 | 96,943,072 | $0.48 | $46,057,654 | 0.82 | 10-Q | | DSCO | WINDTREE THERAPEUTICS INC /DE/ | $20,330,000 | 8,308,736 | $2.05 | $17,032,909 | 0.84 | 10-Q | | VTVT | vTv Therapeutics Inc. | $63,841,000 | 9,690,354 | $5.58 | $54,072,175 | 0.85 | 10-Q | | MIRN | Mirna Therapeutics, Inc. | $30,796,000 | 20,835,868 | $1.27 | $26,453,218 | 0.86 | 10-Q | | GBIM | GLOBEIMMUNE INC | $8,693,718 | 5,751,574 | $1.30 | $7,477,046 | 0.86 | 10-Q | | PLX | Protalix BioTherapeutics, Inc. | $54,626,000 | 99,808,240 | $0.49 | $48,906,038 | 0.90 | 10-Q | | OPXA | Opexa Therapeutics, Inc. | $7,847,360 | 7,049,050 | $1.05 | $7,401,503 | 0.94 | 10-Q | |
